Joseph A. Tyndall
CIK: 0001955281
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Axogen, Inc.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Sep 2, 2026AXGN
Axogen, Inc.
Sale(S)Direct3.5K shares at avg. $49.70$174K - Jun 24, 2026AXGN
Axogen, Inc.
Award(A)DirectRestricted Stock Units
4.4K shares- - Jun 19, 2026AXGN
Axogen, Inc.
Exercise(M)Direct14.2K shares- - Dec 9, 2025AXGN
Axogen, Inc.
Sale(S)Direct10.9K shares at avg. $30.98$336K - Dec 9, 2025AXGN
Axogen, Inc.
Exercise(M)Direct14.2K shares at avg. $7.04$100K - Dec 9, 2025AXGN
Axogen, Inc.
Exercise(M)Direct10.9K shares at avg. $10.95$119K - Dec 9, 2025AXGN
Axogen, Inc.
Sale(S)Direct14.2K shares at avg. $30.98$441K - Jun 19, 2025AXGN
Axogen, Inc.
Award(A)DirectRestricted Stock Units
14.2K shares- - Jun 10, 2025AXGN
Axogen, Inc.
Sale(S)Direct26.9K shares at avg. $10.72$289K - Jun 10, 2025AXGN
Axogen, Inc.
Exercise(M)Direct7.6K shares at avg. $6.30$48K - Jun 10, 2025AXGN
Axogen, Inc.
Exercise(M)Direct4K shares at avg. $7.04$28K - May 22, 2025AXGN
Axogen, Inc.
Exercise(M)Direct12.9K shares at avg. $6.30$81K - May 22, 2025AXGN
Axogen, Inc.
Sale(S)Direct12.9K shares at avg. $11.20$144K - May 22, 2025AXGN
Axogen, Inc.
Sale(S)Direct7.2K shares at avg. $11.20$81K - May 19, 2025AXGN
Axogen, Inc.
Sale(S)Direct2.5K shares at avg. $11.63$29K - Sep 1, 2024AXGN
Axogen, Inc.
Exercise(M)Direct11.9K shares- - Aug 8, 2024AXGN
Axogen, Inc.
Purchase(P)Direct2.5K shares at avg. $10.50$27K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 2, 2026 | AXGN Axogen, Inc. | Sale(S) | 3,500 | $49.70 | $173,940 | Direct |
| Jun 24, 2026 | AXGN Axogen, Inc. | Award(A) Restricted Stock Units | 4,392 | - | - | Direct |
| Jun 19, 2026 | AXGN Axogen, Inc. | Exercise(M) | 14,150 | - | $0 | Direct |
| Dec 9, 2025 | AXGN Axogen, Inc. | Sale(S) | 10,860 | $30.98 | $336,410 | Direct |
| Dec 9, 2025 | AXGN Axogen, Inc. | Exercise(M) | 14,248 | $7.04 | $100,306 | Direct |
| Dec 9, 2025 | AXGN Axogen, Inc. | Exercise(M) | 10,860 | $10.95 | $118,917 | Direct |
| Dec 9, 2025 | AXGN Axogen, Inc. | Sale(S) | 14,248 | $30.98 | $441,360 | Direct |
| Jun 19, 2025 | AXGN Axogen, Inc. | Award(A) Restricted Stock Units | 14,150 | - | - | Direct |
| Jun 10, 2025 | AXGN Axogen, Inc. | Sale(S) | 26,931 | $10.72 | $288,700 | Direct |
| Jun 10, 2025 | AXGN Axogen, Inc. | Exercise(M) | 7,586 | $6.30 | $47,792 | Direct |
| Jun 10, 2025 | AXGN Axogen, Inc. | Exercise(M) | 4,000 | $7.04 | $28,160 | Direct |
| May 22, 2025 | AXGN Axogen, Inc. | Exercise(M) | 12,850 | $6.30 | $80,955 | Direct |
| May 22, 2025 | AXGN Axogen, Inc. | Sale(S) | 12,850 | $11.20 | $143,920 | Direct |
| May 22, 2025 | AXGN Axogen, Inc. | Sale(S) | 7,212 | $11.20 | $80,774 | Direct |
| May 19, 2025 | AXGN Axogen, Inc. | Sale(S) | 2,525 | $11.63 | $29,366 | Direct |
| Sep 1, 2024 | AXGN Axogen, Inc. | Exercise(M) | 11,904 | - | $0 | Direct |
| Aug 8, 2024 | AXGN Axogen, Inc. | Purchase(P) | 2,525 | $10.50 | $26,513 | Direct |
1-17 of 17 transactions
About TYNDALL JOSEPH A.
TYNDALL JOSEPH A. (SEC CIK 0001955281) files insider reports with the SEC as Director of Axogen, Inc. (AXGN).
Signal8 holds 10 ownership filings by TYNDALL JOSEPH A. (9 Form 4, 1 Form 5), filed between Sep 4, 2024 and Sep 4, 2026. Those filings report 17 transactions, from Aug 8, 2024 to Sep 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on TYNDALL JOSEPH A.'s filings is in ALACHUA, FL.
Recent filings by TYNDALL JOSEPH A.
- Sep 2, 2026: Open-market sale of AXGN shares (Form 4, code S).
- Jun 24, 2026: Grant or award of AXGN derivative securities (Form 4, code A).
- Jun 19, 2026: Option exercise of AXGN shares (Form 4, code M).
- Dec 9, 2025: Open-market sale of AXGN shares (Form 4, code S).
- Dec 9, 2025: Option exercises of AXGN shares (2 lines, Form 4, code M).
Other insiders filing for Axogen, Inc. (AXGN)
- Began Marc A, EVP & General Counsel
- Wendell Amy McBride, Director
- Weiler Kathy Johnson, Director
- Burke William P. Mr., Director
- JOHNSON JOHN, Director
- Levine Alan M, Director